Pulmonary function tests are a group of noninvasive breathing tests that measure how much air your lungs can hold, how quickly you can move air in and out and how efficiently your lungs transfer ...

A man with no troubling symptoms was only found to have lung cancer after he was offered a test under a specialist NHS ...

A recent study reveals significant progress in biomarker testing for lung cancer in community settings, highlighting the need ...

Biomarker testing is crucial for personalized oncology care, aiding in risk stratification and treatment decisions, but faces ...

Biodesix, Inc. has announced that new research will be showcased at upcoming conferences, including the ISPOR 2025 Annual Meeting in Montreal and the ATS 2025 International Conference in San Francisco ...

SAN ANTONIO--(BUSINESS WIRE)-- bioAffinity Technologies’ (Nasdaq: BIAF; BIAFW) Vice President of Diagnostics, Jennifer Rebeles, Ph.D., was part of a panel of worldwide experts that published the ...

LOUISVILLE, Colo., May 15, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (BDSX) (Nasdaq: BDSX), a leading diagnostic solutions company, announced that new data will be presented at the International Society ...

When Beverley Moir, a lifelong non-smoker, developed a second lingering cold within six months, she was coughing so severely ...

Lung cancer varies widely from patient to patient, and that diversity makes it hard to find effective treatments. Researchers ...

Understanding those genetic “errors” has become central to modern lung cancer care. Biomarker testing, sometimes called ...

Austin, Texas, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Pulmonary Function Testing Market Size & Growth Analysis: According to SNS Insider, the Pulmonary Function Testing Market size was valued at USD 3.39 ...